These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 10703674

  • 1. Lipoprotein(a) in the nephrotic syndrome: molecular analysis of lipoprotein(a) and apolipoprotein(a) fragments in plasma and urine.
    Doucet C, Mooser V, Gonbert S, Raymond F, Chapman J, Jacobs C, Thillet J.
    J Am Soc Nephrol; 2000 Mar; 11(3):507-513. PubMed ID: 10703674
    [Abstract] [Full Text] [Related]

  • 2. Elevated plasma lipoprotein(a) in patients with the nephrotic syndrome.
    Wanner C, Rader D, Bartens W, Krämer J, Brewer HB, Schollmeyer P, Wieland H.
    Ann Intern Med; 1993 Aug 15; 119(4):263-9. PubMed ID: 8328733
    [Abstract] [Full Text] [Related]

  • 3. Relationship of non-LDL-bound apo(a), urinary apo(a) fragments and plasma Lp(a) in patients with impaired renal function.
    Cauza E, Kletzmaier J, Bodlaj G, Dunky A, Herrmann W, Kostner K.
    Nephrol Dial Transplant; 2003 Aug 15; 18(8):1568-72. PubMed ID: 12897096
    [Abstract] [Full Text] [Related]

  • 4. Lipoprotein(a) in patients with the nephrotic syndrome: influence of immunosuppression and proteinuria.
    Wanner C, Bartens W, Nauck M, Zäuner I, Greiber S, Schollmeyer P.
    Miner Electrolyte Metab; 1996 Aug 15; 22(1-3):26-30. PubMed ID: 8676820
    [Abstract] [Full Text] [Related]

  • 5. Urinary excretion of apolipoprotein(a): relation to other plasma proteins.
    Kostner K, Spitzauer S, Rumpold H, Maurer G, Knipping G, Hrzenjak A, Frank S, Kostner GM.
    Clin Chim Acta; 2001 Feb 15; 304(1-2):29-37. PubMed ID: 11165196
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Urinary excretion of apolipoprotein(a) fragments in type 1 diabetes mellitus patients.
    Clodi M, Oberbauer R, Bodlaj G, Hofmann J, Maurer G, Kostner K.
    Metabolism; 1999 Mar 15; 48(3):369-72. PubMed ID: 10094115
    [Abstract] [Full Text] [Related]

  • 8. High plasma levels of apo(a) fragments in Caucasians and African-Americans with end-stage renal disease: implications for plasma Lp(a) assay.
    Mooser V, Marcovina SM, Wang J, Hobbs HH.
    Clin Genet; 1997 Nov 15; 52(5):387-92. PubMed ID: 9520131
    [Abstract] [Full Text] [Related]

  • 9. Apolipoprotein(a) kringle 4-containing fragments in human urine. Relationship to plasma levels of lipoprotein(a).
    Mooser V, Seabra MC, Abedin M, Landschulz KT, Marcovina S, Hobbs HH.
    J Clin Invest; 1996 Feb 01; 97(3):858-64. PubMed ID: 8609245
    [Abstract] [Full Text] [Related]

  • 10. Molecular analysis of apo(a) fragmentation in polygenic hypercholesterolemia: characterization of a new plasma fragment pattern.
    Gonbert S, Saint-Jore B, Giral P, Doucet C, Chapman J, Thillet J.
    Arterioscler Thromb Vasc Biol; 2001 Aug 01; 21(8):1353-8. PubMed ID: 11498465
    [Abstract] [Full Text] [Related]

  • 11. Urinary excretion of apolipoproteins bound to HDL-like particles in rat nephrotic syndrome and their relation to plasma HDL.
    Shafrir E, Levy E, Deckelbaum R.
    Nephron; 1990 Aug 01; 56(1):24-9. PubMed ID: 2234246
    [Abstract] [Full Text] [Related]

  • 12. Urinary excretion of apo(a) fragments in NIDDM patients.
    Clodi M, Oberbauer R, Waldhäusl W, Maurer G, Kostner GM, Kostner K.
    Diabetologia; 1997 Dec 01; 40(12):1455-60. PubMed ID: 9447954
    [Abstract] [Full Text] [Related]

  • 13. Urinary apolipoprotein (a) excretion in patients with proteinuria.
    Kostner KM, Banyai S, Banyai M, Bodlaj G, Maurer G, Derfler K, Hörl WH, Oberbauer R.
    Ann Med; 1998 Oct 01; 30(5):497-502. PubMed ID: 9814837
    [Abstract] [Full Text] [Related]

  • 14. Kringle-containing fragments of apolipoprotein(a) circulate in human plasma and are excreted into the urine.
    Mooser V, Marcovina SM, White AL, Hobbs HH.
    J Clin Invest; 1996 Nov 15; 98(10):2414-24. PubMed ID: 8941661
    [Abstract] [Full Text] [Related]

  • 15. Reduction of lipoprotein(a) following treatment with lovastatin in patients with unremitting nephrotic syndrome.
    Brown CD, Azrolan N, Thomas L, Roberts KG, Bostom A, Zhao ZH, Friedman EA.
    Am J Kidney Dis; 1995 Jul 15; 26(1):170-7. PubMed ID: 7611249
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Decreased urinary apolipoprotein (a) excretion in patients with impaired renal function.
    Kostner KM, Clodi M, Bodlaj G, Watschinger B, Hörl W, Derfler K, Huber K.
    Eur J Clin Invest; 1998 Jun 15; 28(6):447-52. PubMed ID: 9693935
    [Abstract] [Full Text] [Related]

  • 18. The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rate.
    Rader DJ, Cain W, Ikewaki K, Talley G, Zech LA, Usher D, Brewer HB.
    J Clin Invest; 1994 Jun 15; 93(6):2758-63. PubMed ID: 8201014
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Lipoprotein Lp(a) in homozygous familial hypercholesterolemia: density profile, particle heterogeneity and apolipoprotein(a) phenotype.
    Guo HC, Chapman MJ, Bruckert E, Farriaux JP, De Gennes JL.
    Atherosclerosis; 1991 Jan 15; 86(1):69-83. PubMed ID: 1829609
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.